Prosecution Insights
Last updated: April 19, 2026

Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis

5 pending office actions

Portfolio Summary

5
Total Pending OAs
0
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18684964 INJECTION DEVICE, INJECTION ASSEMBLY AND MONITORING DEVICE WEARE, MEREDITH H 3791 Non-Final OA Feb 20, 2024
18272419 INDUCERS OF SENESCENCE, IN COMBINATION WITH A SELECTIVE DEATH RECEPTOR 5 (DR5) AGONIST, FOR USE IN A METHOD OF TREATING CANCER MCANANY, JOHN D 1625 Non-Final OA Jul 14, 2023
17923671 FLUID INJECTION DEVICE FOR INJECTING A FLUID BEHIND THE TYMPANIC MEMBRANE DAVIS, JASON GREGORY 3745 Non-Final OA Nov 07, 2022
17909553 MODULATING ANTI-TUMOR IMMUNITY SHUPE, ELIZABETH A 1643 Non-Final OA Sep 06, 2022
17619076 SODIUM THIOSULFATE GEL FOR PREVENTING OR REDUCING HEARING LOSS WEBB, WALTER E 1612 Non-Final OA Dec 14, 2021

Managing Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month